Vaccines and therapeutics for immunocompromised patients with COVID-19-Reference-Cited by-同舟云学术

Vaccines and therapeutics for immunocompromised patients with COVID-19

Published:2023-05 Issue: Volume:59 Page:101965
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Shoham Shmuel^ORCID,Batista Carolina,Ben Amor Yanis,Ergonul Onder,Hassanain Mazen,Hotez Peter,Kang Gagandeep^ORCID,Kim Jerome H.,Lall Bhavna,Larson Heidi J.,Naniche Denise,Sheahan Timothy,Strub-Wourgaft Nathalie,Sow Samba O.,Wilder-Smith Annelies,Yadav Prashant,Bottazzi Maria Elena^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference78 articles.

1. Prevalence of immunosuppression among US adults, 2013;Harpaz;JAMA,2016

2. COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients;Belsky;J Infect,2021

3. COVID-19 and kidney transplantation: results from the TANGO international transplant consortium;Cravedi;Am J Transplant,2020

4. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients;Boyarsky;JAMA,2021

5. Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: a case series;Werbel;Ann Intern Med,2021

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination strategies for patients under monoclonal antibody and other biological treatments: an updated comprehensive review based on EMA authorizations to January 2024;Expert Review of Vaccines;2024-09-11

2. No more government-imposed societal-level COVID-19 control measures but still significant self-experienced burden for severely immunocompromised individuals – A cross-sectional survey in the Netherlands;Preventive Medicine Reports;2024-09

3. COVID-19 in the immunocompromised host;COVID-19: An Update;2024-09-01

4. Drug susceptibility and the potential for drug-resistant SARS-CoV-2 emergence in immunocompromised animals;iScience;2024-09

5. Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection;Journal of Virology;2024-08-29